ธนิยา เจริญเสรีรัตน์

1.Chaijamorn W, Phunpon S, Sathienluckana T, Charoensareerat T, Pattharachayakul S, Rungkitwattanakul D and Srisawat N. (2023). Lacosamide dosing in patients receiving continuous renal replacement therapy. Journal of Intensive Care, 11(50), 1-9. https://doi.org/10.1186/s40560-023-00700-4

2.Abbasi M.Y., Chaijamorn W., Wiwattanawongsa K., Charoensareerat T., Doungngern T. (2023). What is the right gentamicin dose for multiple trauma patients? A Monte Carlo simulation exploration study. International Journal of Critical Illness and Injury Science, 13(3), 118-124. Jul–Sep 2023. DOI: 10.4103/ijciis.ijciis_14_23

3.Chongtrakool P, Charoensareerat T, Tribuddharat C, Samretwit D, Chaikulsareewath A, Noiduang P, Thuncharoon H, Yungyuen T and Srifuengfung S. (2023, Sep). MICROBIAL, STEROIDS AND HEAVY METALS CONTAMINATION AND ANTIMICROBIAL RESISTANCE OF BACTERIAL ISOLATES IN THAI HERBAL PRODUCTS. The Southeast Asian Journal of Tropical Medicine and Public Health, 54(5), 118-124. September 2023. https://journal.seameotropmednetwork.org/index.php/jtropmed/article/view/865

4.Rungkitwattanakul, D., Charoensareerat, T., Chaichoke, E., Rakamthong, T., Srisang, P., Pattharachayakul, S., Srisawat, N., & Chaijamorn, W. (2023). Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy. Semin Dial. 7(1), 468-476.

5.Rungkitwattanakul D , Charoensareerat T , Chaichoke E , Rakamthong T , Srisang P , Pattharachayakul S , Srisawat N , Chaijamorn W. (2023, Feb). Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy. Seminars in Dialysis, 1-9

6.Charoensareerat T, Chaijamorn W, Kerdnimith P, Kosumwisaisakul N, Teeranaew P, Rungkitwattanakul D, Boonpeng A, Srisawate N & Pattharachayakul S. (2023). Optimal Meropenem Dosing Regimens in Patients Undergoing Continuous Renal Replacement Therapy: Systematic Review and Monte Carlo Simulations. Blood Purification, 52, 503-515

7.Abbasi M.Y., Chaijamorn W., Wiwattanawongsa K., Charoensareerat T., Doungngern T. (2023). Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach. Clinical Pharmacology: Advances and Applications, 15, 67-76. https://doi.org/10.2147/CPAA.S417298

8.Rungkitwattanakul, D., Charoensareerat, T., Kerdnimith, P., Kosumwisaisakul, N., Teeranaew, P., Boonpeng, A., Pattharachayakul, S., Srisawat, N., & Chaijamorn, W. (2021). Imipenem dosing recommendations for patients undergoing continuous renal replacement therapy: systematic review and Monte Carlo simulations. Renal Replacement Therapy, 7(1), 61. https://doi.org/10.1186/s41100-021-00380-6

9.Charoensareerat, T., Bhurayanontachai, R., Sitaruno, S., Navasakulpong, A., Boonpeng, A., Lerkiatbundit, S., & Pattharachayakul, S. (2021). Efficacy and Safety of Enteral Erythromycin Estolate in Combination with Intravenous Metoclopramide vs Intravenous Metoclopramide Monotherapy in Mechanically Ventilated Patients with Enteral Feeding Intolerance: A Randomized, Double-Blind, Controlled Pilot Study. JPEN J Parenter Enteral Nutr, 45(6), 1309-1318. https://doi.org/10.1002/jpen.2013

10.Chaijamorn, W., Charoensareerat, T., Rungkitwattanakul, D., Phunpon, S., Sathienluckana, T., Srisawat, N., & Pattharachayakul, S. (2021). Levetiracetam dosing in patients receiving continuous renal replacement therapy. Epilepsia, 62(9), 2151-2158. https://doi.org/10.1111/epi.16971

11.Rungkitwattanakul, D., Chaijamorn, W., Charoensareerat, T., Charntrakarn, P., Khamkampud, O., Rattanaponpasert, N., Srisawat, N., & Pattharachayakul, S. (2021). Optimal levofloxacin dosing regimens in critically ill patients with acute kidney injury receiving continuous renal replacement therapy. J Crit Care, 63, 154-160.
12.Chaijamorn, W., Rungkitwattanakul, D., Nuchtavorn, N., Charoensareerat, T., Pattharachayakul, S., Sirikun, W., & Srisawat, N. (2020). Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy. Critical Care Explorations, 2(10), e0242. https://doi.org/10.1097/cce.0000000000000242

13.Chaijamorn, W., Rungkitwattanakul, D., Pattharachayakul, S., Singhan, W., Charoensareerat, T., & Srisawat, N. (2020). Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy. J Crit Care, 60, 285-289. https://doi.org/https://doi.org/10.1016/j.jcrc.2020.09.001